Ankylosing Spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine. It is estimated that 0.1% to 0.5% of the global population is affected by AS, making it a relatively rare condition. AS is more prevalent in men than women, with a male-to-female ratio of approximately 3:1. The prevalence of AS varies across different populations and ethnicities, with higher rates reported in certain regions. Early diagnosis and appropriate management are crucial in improving the quality of life for individuals living with AS.
Ankylosing Spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. It is classified as a type of arthritis and can lead to severe pain, stiffness, and reduced mobility. The prevalence of AS varies across different populations and regions.
According to various studies and estimates, the prevalence of AS ranges from 0.1% to 1.4% globally. However, it is important to note that these figures may not accurately represent the true prevalence due to underdiagnosis and misdiagnosis. AS is more commonly diagnosed in males than females, with a male-to-female ratio of approximately 3:1.
AS typically manifests in early adulthood, with symptoms often appearing between the ages of 15 and 30. The disease tends to progress over time, potentially leading to spinal fusion and significant disability. Early diagnosis and appropriate treatment can help manage symptoms and slow down disease progression.
If you suspect you may have AS or are experiencing symptoms such as chronic back pain and stiffness, it is crucial to consult a healthcare professional for an accurate diagnosis and appropriate management.